Clinical Trial Update: Caffeine in Amblyopia Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial investigating caffeine for amblyopia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amblyopia

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Amblyopia | Phase 1, Phase 2 | Status: WITHDRAWN